Send the following on WhatsApp
Continue to ChatTofersen: antisense oligonucleotide drug shows promising results in Phase 1/2 trial https://mndresearch.blog/2019/05/07/tofersen-antisense-oligonucleotide-drug-shows-promising-results-in-phase-1-2-trial/